Influence of study sponsorship on head and neck cancer randomized trial results.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 22987508)

Published in Head Neck on September 18, 2012

Authors

Gordon H Sun1, Jeffrey J Houlton, Mark P MacEachern, Carol R Bradford, Rodney A Hayward

Author Affiliations

1: Robert Wood Johnson Foundation Clinical Scholars, University of Michigan, Ann Arbor, Michigan; VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan; Department of Otolaryngology - Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.

Articles by these authors

(truncated to the top 100)

Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86

Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA (2007) 5.60

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46

The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med (2002) 4.79

A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med (2003) 3.81

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79

Lessons from the mammography wars. N Engl J Med (2010) 3.68

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials (2010) 3.45

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 3.39

Are bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade iatrogenesis. Ann Intern Med (2002) 3.07

Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med (2007) 3.05

Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care (2003) 2.88

Patients, privacy and trust: patients' willingness to allow researchers to access their medical records. Soc Sci Med (2006) 2.86

Building a better quality measure: are some patients with 'poor quality' actually getting good care? Med Care (2003) 2.85

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck (2010) 2.76

Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures. Ann Intern Med (2003) 2.75

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med (2004) 2.73

Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res (2002) 2.68

Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck (2010) 2.51

Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation (2008) 2.45

Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol (2010) 2.41

Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med (2004) 2.41

Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med (2005) 2.32

Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol (2007) 2.25

An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ (2010) 2.22

Uninsured adults presenting to US emergency departments: assumptions vs data. JAMA (2008) 2.15

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med (2002) 2.12

Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res (2010) 2.11

Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med (2010) 2.06

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys (2004) 2.00

Lean management in academic surgery. J Am Coll Surg (2012) 1.97

Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology (2008) 1.95

Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92

Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med (2011) 1.92

Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 1.91

A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res (2006) 1.85

Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 1.83

How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care (2003) 1.81

Does physician communication influence older patients' diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci (2007) 1.80

Performance measurement in search of a path. N Engl J Med (2007) 1.78

Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol Cancer Ther (2005) 1.70

The impact of diabetes on workforce participation: results from a national household sample. Health Serv Res (2004) 1.70

Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation (2007) 1.68

Specialty care and the patient-centered medical home. Med Care (2011) 1.68

Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care (2005) 1.64

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer (2007) 1.64

What causes pregnancy loss? Preexisting mental illness as an independent risk factor. Gen Hosp Psychiatry (2007) 1.63

All-or-nothing treatment targets make bad performance measures. Am J Manag Care (2007) 1.61

Marriage and cohabitation outcomes after pregnancy loss. Pediatrics (2010) 1.61

New diabetes HEDIS blood pressure quality measure: potential for overtreatment. Am J Manag Care (2010) 1.60

In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells. Clin Cancer Res (2004) 1.55

Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55

(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia (2006) 1.55

When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med (2004) 1.53

Open-access electronic case report journals: the rationale for case report guidelines. J Clin Epidemiol (2013) 1.51

Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures. Jt Comm J Qual Improv (2002) 1.48

UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck (2011) 1.45

Shifting views on lipid lowering therapy. BMJ (2010) 1.44

Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2012) 1.38

Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope (2002) 1.35

Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res (2008) 1.35

Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33

Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys (2011) 1.33

Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck (2002) 1.32

Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2010) 1.31

Interhospital transfers among Medicare beneficiaries admitted for acute myocardial infarction at nonrevascularization hospitals. Circ Cardiovasc Qual Outcomes (2010) 1.31

Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys (2007) 1.31

Patient-centered performance management: enhancing value for patients and health care systems. JAMA (2013) 1.29

Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28

CKD progression and mortality among older patients with diabetes. Am J Kidney Dis (2005) 1.24

Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care (2010) 1.23

Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.23

HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck (2010) 1.23

Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer. Mol Cancer Ther (2008) 1.22

Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection. Head Neck (2002) 1.21

The rheumatoid hand: a predictable disease with unpredictable surgical practice patterns. Arthritis Rheum (2002) 1.20

Surgical margins in head and neck cancer: a contemporary review. Head Neck (2012) 1.19

Pectoralis major myocutaneous flap vs revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization. Arch Otolaryngol Head Neck Surg (2004) 1.19

Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck (2012) 1.18

Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope (2009) 1.17

Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol (2011) 1.16

Informal caregiving for diabetes and diabetic complications among elderly americans. J Gerontol B Psychol Sci Soc Sci (2002) 1.13

Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release. Cancer Res (2007) 1.12

Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines. Circ Cardiovasc Qual Outcomes (2011) 1.11

The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys (2009) 1.10

Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 1.10

The relative merits of population-based and targeted prevention strategies. Milbank Q (2008) 1.10

Improving eye care for veterans with diabetes: an example of using the QUERI steps to move from evidence to implementation: QUERI Series. Implement Sci (2008) 1.09

Physical activity and mortality across cardiovascular disease risk groups. Med Sci Sports Exerc (2004) 1.07

Quality by any other name?: a comparison of three profiling systems for assessing health care quality. Health Serv Res (2007) 1.07

Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials. Circ Cardiovasc Qual Outcomes (2014) 1.07

The association between three different measures of health status and satisfaction among patients with diabetes. Med Care Res Rev (2003) 1.06

Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck (2002) 1.06

Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope (2002) 1.05

Access to clinically-detailed patient information: a fundamental element for improving the efficiency and quality of healthcare. Med Care (2008) 1.05

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys (2005) 1.04